ViroMed Co., Ltd. is a Korea-based company engaged in the development and manufacture of biopharmaceuticals. The Company produces natural pharmaceuticals, deoxyribonucleic acid (DNA) vaccines, protein antibodies and others, which are used for therapy of various diseases, including cardiovascular diseases, such as peripheral artery disease and coronary artery disease; neuropathy diseases, such as diabetic peripheral neuropathy disease; cancer, such as breast cancer and thrombocytopenia; arthritis, such as osteoarthritis, and allergy, such as atopic dermatitis and muscular fatigue. As of December 31, 2011, the Company had one wholly owned subsidiary, engaged in the development and research life science.